AbCellera Biologics (ABCL) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$3.91

-0.01 (-0.26%)

(As of 05:17 PM ET)

Source

Source	Headline
	AbCellera Biologics (NASDAQ:ABCL) Hits New 12-Month Low at $3.84 marketbeat.com - April 18 at 10:58 AM
	AbCellera Biologics Inc. (ABCL) finance.yahoo.com - April 18 at 8:03 AM
	AbCellera Biologics Inc. (NASDAQ:ABCL) Shares Sold by Baillie Gifford & Co. marketbeat.com - April 10 at 8:34 AM
	AbCellera Biologics (NASDAQ:ABCL) Shares Up 5.1% marketbeat.com - April 9 at 3:19 PM
	AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 businesswire.com - April 8 at 12:05 PM
	AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Rating of "Buy" from Analysts marketbeat.com - April 6 at 2:58 AM
	AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 businesswire.com - April 3 at 4:05 PM
	AbCellera Biologics (NASDAQ:ABCL) Trading Down 3.8% marketbeat.com - April 1 at 2:58 PM
	The 7 Best Penny Stocks to Buy in Q2 2024 investorplace.com - March 27 at 4:30 PM
	Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks finance.yahoo.com - March 27 at 1:54 AM
	AbCellera Biologics (NASDAQ:ABCL) Stock Price Down 3.7% marketbeat.com - March 26 at 4:46 PM
	AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 businesswire.com - March 19 at 4:05 PM
	AbCellera gains on antibody collaboration with Biogen msn.com - March 11 at 4:45 PM
	AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 4.8% marketbeat.com - March 11 at 11:52 AM
	Schonfeld Strategic Advisors LLC Acquires 211,000 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) marketbeat.com - March 9 at 5:42 AM
	AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 businesswire.com - March 5 at 4:30 PM
	Trexquant Investment LP Has $1.25 Million Position in AbCellera Biologics Inc. (NASDAQ:ABCL) marketbeat.com - March 5 at 7:53 AM
	Barclays PLC Sells 504,978 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) marketbeat.com - March 3 at 4:11 AM
	After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain finance.yahoo.com - February 29 at 8:14 AM
	AbCellera: Victim Of Its Own Success seekingalpha.com - February 28 at 12:36 PM
	Federated Hermes Inc. Cuts Position in AbCellera Biologics Inc. (NASDAQ:ABCL) marketbeat.com - February 26 at 7:21 AM
	3 Highly Rated Biotech Stocks to Buy for 300% Gains investorplace.com - February 26 at 6:55 AM
	Piper Sandler Reaffirms Their Buy Rating on AbCellera Biologics (ABCL) markets.businessinsider.com - February 23 at 7:14 PM
	AbCellera Announces Resignation of Board Member businesswire.com - February 23 at 4:30 PM
	ABCL Mar 2024 4.000 call finance.yahoo.com - February 23 at 2:14 PM
	ABCL Mar 2024 5.000 call finance.yahoo.com - February 23 at 12:41 PM
	AbCellera Biologics Inc. (NASDAQ:ABCL) Shares Bought by Dark Forest Capital Management LP marketbeat.com - February 23 at 7:52 AM
	AbCellera Biologics Inc. to Post Q1 2024 Earnings of ($0.14) Per Share, Bloom Burton Forecasts (NASDAQ:ABCL) marketbeat.com - February 23 at 7:17 AM
	Benchmark Upgrades AbCellera Biologics (ABCL) msn.com - February 23 at 1:16 AM
	AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls benzinga.com - February 22 at 8:16 PM
	AbCellera to Present at Upcoming Investor Conferences in March businesswire.com - February 22 at 8:15 PM
	Obesity drugs to expand U.S. GDP by 1% in the coming years: Goldman Sachs msn.com - February 22 at 3:56 PM
	AbCellera Biologics Stock (NASDAQ:ABCL) Insider Trades benzinga.com - February 22 at 10:55 AM
	Stifel Nicolaus Reaffirms Their Buy Rating on AbCellera Biologics (ABCL) markets.businessinsider.com - February 22 at 9:31 AM
	Analysts Offer Predictions for AbCellera Biologics Inc.'s Q1 2025 Earnings (NASDAQ:ABCL) marketbeat.com - February 22 at 7:50 AM
	AbCellera Biologics (NASDAQ:ABCL) Raised to "Buy" at Benchmark marketbeat.com - February 22 at 7:20 AM
	AbCellera Biologics (NASDAQ:ABCL) Shares Down 5.8% on Analyst Downgrade marketbeat.com - February 21 at 10:27 AM
	Stifel Nicolaus Trims AbCellera Biologics (NASDAQ:ABCL) Target Price to $17.00 marketbeat.com - February 21 at 9:33 AM
	Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), GeneDx Holdings (WGS) and Halozyme (HALO) markets.businessinsider.com - February 21 at 7:49 AM
	Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and AbCellera Biologics (ABCL) markets.businessinsider.com - February 21 at 7:49 AM
	Q4 2023 Abcellera Biologics Inc Earnings Call finance.yahoo.com - February 21 at 7:49 AM
	Recap: AbCellera Biologics Q4 Earnings benzinga.com - February 20 at 8:34 PM
	AbCellera Reports Full Year 2023 Business Results finance.yahoo.com - February 20 at 8:34 PM
	AbCellera Biologics Inc (ABCL) Faces Net Loss in FY 2023 Amid Strategic Shifts finance.yahoo.com - February 20 at 8:34 PM
	AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates finance.yahoo.com - February 20 at 8:34 PM
	AbCellera Reports Full Year 2023 Business Results businesswire.com - February 20 at 4:05 PM
	Baillie Gifford & Co. Has $120.54 Million Stock Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL) marketbeat.com - February 16 at 11:28 AM
	AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Consensus Recommendation of "Moderate Buy" from Analysts marketbeat.com - February 16 at 1:44 AM
	AbCellera Biologics: Continuing To Expand Partnerships seekingalpha.com - February 13 at 3:50 PM
	AbCellera Biologics Inc. (NASDAQ:ABCL) Stock Holdings Lowered by Jump Financial LLC marketbeat.com - February 5 at 5:27 AM

Get AbCellera Biologics News Delivered to You Automatically

The Next Nvidia? (Ad)

The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

Go here now for this breaking story.

ABCL Media Mentions By Week

ABCL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABCL
News Sentiment
▼
1.76

0.49
▲
Average
Medical
News Sentiment

ABCL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABCL Articles
This Week
▼
2

2
▲
ABCL Articles
Average Week

Get AbCellera Biologics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ABCL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

AbCellera Biologics (ABCL) News Today

ABCL Media Mentions By Week

ABCL Media Sentiment

ABCL News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info